Supriya Lifescience Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 14 shareholders own 77.04% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
67.6%	Satish Wagh	54,441,205	₹21.8b	0%	no data
3.6%	Aditya Birla Sun Life AMC Limited	2,899,154	₹1.2b	-2.06%	0.07%
1.99%	Nippon Life India Asset Management Limited	1,603,832	₹641.8m	-46.2%	0.02%
1.89%	Hornbill Capital Advisers LLP	1,520,000	₹608.2m	0%	14.3%
1.13%	Dovetail India Fund Class 6 Shares	912,384	₹365.1m	0%	no data
0.4%	Smita Wagh	321,750	₹128.7m	0%	no data
0.13%	Shivani Wagh	102,375	₹41.0m	250%	no data
0.13%	Saloni Wagh	102,375	₹41.0m	-41.7%	no data
0.048%	Motilal Oswal Asset Management Company Limited	38,859	₹15.5m	32.7%	no data
0.046%	State Street Global Advisors, Inc.	36,732	₹14.7m	0%	no data
0.027%	Dimensional Fund Advisors LP	21,526	₹8.6m	349%	no data
0.0088%	BNY Mellon Asset Management	7,049	₹2.8m	37.2%	no data
0.00021%	Groww Asset Management Limited	173	₹67.6k	69.6%	no data
0.00001%	Supriya Pharmaceuticals Partnership Firm	10	₹3.2k	0%	no data